Patents by Inventor Ami A. Shah

Ami A. Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MATERIALS AND METHODS FOR ASSESSING CANCER RISK AND TREATING CANCER
    Publication number: 20220412980
    Abstract: This document relates to materials and methods for assessing and/or treating subjects (e.g., subjects having autoimmune diseases). For example, materials and methods for determining if a subject (e.g., a human having an autoimmune disease) has one or more antibodies that can be used to identify the subject as having a lower risk of cancer or as having a higher risk of cancer are provided. Materials and methods for treating a subject (e.g., a human) identified as having a higher cancer risk for cancer are also provided.
    Type: Application
    Filed: August 18, 2022
    Publication date: December 29, 2022
    Inventors: Ami A. Shah, Livia Casciola-Rosen, Antony Rosen, Takeru Igusa, Marikki K. Laiho
  • Materials and methods for assessing cancer risk and treating cancer
    Patent number: 11454630
    Abstract: This document relates to materials and methods for assessing and/or treating subjects (e.g., subjects having autoimmune diseases). For example, materials and methods for determining if a subject (e.g., a human having an autoimmune disease) has one or more antibodies that can be used to identify the subject as having a lower risk of cancer or as having a higher risk of cancer are provided. Materials and methods for treating a subject (e.g., a human) identified as having a higher cancer risk for cancer are also provided.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: September 27, 2022
    Assignee: The Johns Hopkins University
    Inventors: Ami A. Shah, Livia Casciola-Rosen, Antony Rosen, Takeru Igusa, Marikki K. Laiho
  • AUTOIMMUNE ANTIGENS AND CANCER
    Publication number: 20210100882
    Abstract: Autoimmune diseases are thought to be initiated by exposures to foreign antigens that cross-react with endogenous molecules. Analyses of peripheral blood lymphocytes and serum suggested that mutations in autoimmune antigen targets sparked cellular immunity and cross-reactive humoral immune responses. Acquired immunity to autoimmune antigens can help control naturally occurring cancers.
    Type: Application
    Filed: October 22, 2020
    Publication date: April 8, 2021
    Inventors: Erika Darrah, Ami A. Shah, Livia A. Casciola-Rosen, Antony Rosen, Christine Joseph, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos
  • Autoimmune antigens and cancer
    Patent number: 10874726
    Abstract: Autoimmune diseases are thought to be initiated by exposures to foreign antigens that cross-react with endogenous molecules. Analyses of peripheral blood lymphocytes and serum suggested that mutations in autoimmune antigen targets sparked cellular immunity and cross-reactive humoral immune responses. Acquired immunity to autoimmune antigens can help control naturally occurring cancers.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: December 29, 2020
    Assignee: The Johns Hopkins University
    Inventors: Erika Darrah, Ami A. Shah, Livia A. Casciola-Rosen, Antony Rosen, Christine Joseph, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos
  • MATERIALS AND METHODS FOR ASSESSING CANCER RISK AND TREATING CANCER
    Publication number: 20200209245
    Abstract: This document relates to materials and methods for assessing and/or treating subjects (e.g., subjects having autoimmune diseases). For example, materials and methods for determining if a subject (e.g., a human having an autoimmune disease) has one or more antibodies that can be used to identify the subject as having a lower risk of cancer or as having a higher risk of cancer are provided. Materials and methods for treating a subject (e.g., a human) identified as having a higher cancer risk for cancer are also provided.
    Type: Application
    Filed: August 23, 2018
    Publication date: July 2, 2020
    Inventors: Ami A. Shah, Livia Casciola-Rosen, Antony Rosen, Takeru Igusa, Marikki K. Laiho
  • Autoimmune Antigens and Cancer
    Publication number: 20160303209
    Abstract: Autoimmune diseases are thought to be initiated by exposures to foreign antigens that cross-react with endogenous molecules. Analyses of peripheral blood lymphocytes and serum suggested that mutations in autoimmune antigen targets sparked cellular immunity and cross-reactive humoral immune responses. Acquired immunity to autoimmune antigens can help control naturally occurring cancers.
    Type: Application
    Filed: December 4, 2014
    Publication date: October 20, 2016
    Applicant: The Johns Hopkins University
    Inventors: Erika Darrah, Ami A. Shah, Livia A. Casciola-Rosen, Anthony Rosen, Christine Joseph, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos